Elizabeth Orr
Managing Editor, Policy & Regulation
Elizabeth leads a team of Medtech Insight reporters devoted to covering medical device and diagnostics regulation in the US and abroad. As a reporter, she focuses on FDA regulation, legislation, and legal issues. A graduate of the University of Maryland College Park, she worked for outlets including FDA News, DecisionHealth (formerly UCG) and the Washington Examiner before joining Medtech Insight in 2015. She lives in Arlington, VA, with her husband and children.
Latest From Elizabeth Orr
New Warning Label Added To AFX2 Endovascular Graft
The US FDA released updated safety information on Endologix Inc.’s AFX2 Endovascular abdominal aortic aneurysm (AAA) graft system on Tuesday. Previous devices in the product line have been associated with an increased risk of abnormal bleeding.
It’s A Class I Recall For Baxter’s WatchCare Device
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.
It’s A Class I Recall For Baxter’s WatchCare Device
Radiofrequencies from the incontinence-sensing devices may interfere with other medical equipment in a hospital setting.
Ex-Theranos CEO Elizabeth Holmes Sentenced To 11-Year Prison Term
The former diagnostics company executive was convicted in January on four counts of fraud.
Roche Wins FDA Authorization On High-Volume Monkeypox Test
The test, which is the first for the condition to win an EUA using actual patient samples, provides results in about three and a half hours.
Philips Admits New Issues In Reworked Ventilators
A silicone foam that replaced hazardous polyurethane in some reworked Philips Trilogy ventilators could separate from the unit and block air flow; additionally, particles have been found in ventilator air pathways.